Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RE-COVER I: Dabigatran vs Warfarin for Acute VTE
NCT00291330Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Feb 2006
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 29
01
Overview
A Phase 3 trial of dabigatran in venous thromboembolism (VTE), sponsored by Boehringer Ingelheim. Started Feb 2006; status: completed.
02
Drugs
dabigatran
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT00291330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00291330.